PVLA insider trading
HealthcarePALVELLA THERAPEUTICS, INC.: insider trade history from SEC Form 4 filings.
About PALVELLA THERAPEUTICS, INC.
Palvella Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel therapies to treat patients serious and rare genetic skin diseases. The company's lead product candidate is QTORIN 3.9% rapamycin anhydrous gel that is in Phase 3 clinical trial for the treatment of microcystic lymphatic malformations, as well as in Phase 2 clinical trial to treat cutaneous venous malformations. It also develops QTORIN rapamycin for the treatment of other mTOR-driven skin diseases. The company is based in Wayne, Pennsylvania
Company website: palvellatx.com
PVLA insider activity at a glance
FilingIQ tracks 76 insider transactions for PVLA in filings since Dec 17, 2024. The most recent transaction is dated Sep 16, 2026.
Across the full history, 6 open-market purchases
and 43 open-market sales
were filed under transaction codes P and S respectively. Compensatory share awards
(code A) and option exercises (code M) are tracked separately and not counted here.
The average FilingIQ composite score on PVLA insider trades is 53.9/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.
Latest PVLA Form 4 filings
Most recent disclosures. Sign up to filter by score, transaction code, or insider role.
Other Healthcare tickers with recent insider activity
Frequently asked
- How many insider trades does FilingIQ track for PVLA?
- FilingIQ tracks 76 Form 4 insider transactions for PVLA (PALVELLA THERAPEUTICS, INC.), covering filings from Dec 17, 2024 onwards. 29 of those are dated within the last 90 days.
- Are PVLA insiders net buyers or net sellers?
- Across the full Form 4 history for PVLA, 6 transactions (8%) were open-market purchases and 43 (57%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
- Where does PVLA insider data come from?
- Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ normalises insider identity across reporting variations and scores discretionary open-market purchases and sales on its multi-factor composite model.
- What sector is PVLA in?
- PALVELLA THERAPEUTICS, INC. (PVLA) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $929.58M.
Methodology & sources
Every PVLA insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.